Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C28H24N6 |
| Molecular Weight | 444.5304 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Charge | 2 |
SHOW SMILES / InChI
SMILES
CC1=C(N(\N=N\N2C3=[N+](C=CC=C3)C(C)=C2C4=CC=CC=C4)C5=[N+]1C=CC=C5)C6=CC=CC=C6
InChI
InChIKey=NJAGGYXZTILBMJ-QVIHXGFCSA-N
InChI=1S/C28H24N6/c1-21-27(23-13-5-3-6-14-23)33(25-17-9-11-19-31(21)25)29-30-34-26-18-10-12-20-32(26)22(2)28(34)24-15-7-4-8-16-24/h3-20H,1-2H3/q+2/b30-29+
| Molecular Formula | C28H24N6 |
| Molecular Weight | 444.5304 |
| Charge | 2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 1 |
| Optical Activity | NONE |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/6113885
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6113885
Fazadinium (used as a bromide salt) is a muscle relaxant, which was applied in anesthesia under the name Fazadon. The current marketing status is unknown and the drug is supposed to be discontinued.
Originator
Approval Year
T1/2
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
82 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6107098/ |
1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: THIOPENTAL SODIUM |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
|
153 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6107098/ |
1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: THIOPENTAL SODIUM |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
|
103 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6107098/ |
1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: THIOPENTAL SODIUM |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
|
30.2 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6108730/ |
0.5 mg/kg single, intravenous dose: 0.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
50.1 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6108730/ |
1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
76.4 min |
1.5 mg/kg single, intravenous dose: 1.5 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
85 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/42420/ |
1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: THIOPENTAL SODIUM |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
|
140 min EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/42420/ |
1 mg/kg single, intravenous dose: 1 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: THIOPENTAL SODIUM |
FAZADINIUM plasma | Homo sapiens population: UNHEALTHY age: ADULT sex: FEMALE / MALE food status: UNKNOWN |
Funbound
| Value | Dose | Co-administered | Analyte | Population |
|---|---|---|---|---|
49% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6122460/ |
FAZADINIUM serum | Homo sapiens population: HEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
||
43% EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/6122460/ |
FAZADINIUM serum | Homo sapiens population: UNHEALTHY age: ADULT sex: UNKNOWN food status: UNKNOWN |
Doses
| Dose | Population | Adverse events |
|---|---|---|
1.5 mg/kg single, intravenous Highest studied dose Dose: 1.5 mg/kg Route: intravenous Route: single Dose: 1.5 mg/kg Sources: |
healthy, ADULT Health Status: healthy Age Group: ADULT Sex: M+F Food Status: UNKNOWN Sources: |
|
37 mg single, intravenous Studied dose Dose: 37 mg Route: intravenous Route: single Dose: 37 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: F Food Status: UNKNOWN Sources: |
Other AEs: Death... |
45 mg single, intravenous Studied dose Dose: 45 mg Route: intravenous Route: single Dose: 45 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
Other AEs: Cardiovascular collapse... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Death | grade 5 | 37 mg single, intravenous Studied dose Dose: 37 mg Route: intravenous Route: single Dose: 37 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: F Food Status: UNKNOWN Sources: |
| Cardiovascular collapse | 45 mg single, intravenous Studied dose Dose: 45 mg Route: intravenous Route: single Dose: 45 mg Sources: |
unhealthy, ADULT Health Status: unhealthy Age Group: ADULT Sex: M Food Status: UNKNOWN Sources: |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6113885
The recommended dose is 1.5 mg/kg.
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6108148
The guinea-pig isolated hypogastric nerve-vas deferens preparation and isolated phrenic nerve-diaphragm preparation were incubated with fazadinium at a concentration from 10(-5) to 3.2*10(-4) M. EC50 for neuromuscular blockade was 2.8*10(-5) M and EC50 for ganglion blockade was 6.4*10(-5) M.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:19:22 GMT 2025
by
admin
on
Mon Mar 31 18:19:22 GMT 2025
|
| Record UNII |
0R97XIX3OA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29696
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
||
|
WHO-ATC |
M03AC08
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
||
|
NCI_THESAURUS |
C66886
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB02104MIG
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
C80979
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
100000087500
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
C084773
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
Fazadinium
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
0R97XIX3OA
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
4535
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
DTXSID801021594
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
36653-54-0
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY | |||
|
5487713
Created by
admin on Mon Mar 31 18:19:22 GMT 2025 , Edited by admin on Mon Mar 31 18:19:22 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |